{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:34:37Z","timestamp":1792028077724,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1095,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>A patient receiving a liver graft needs to be treated with immunosuppressive drugs to avoid rejection. These kinds of drugs predispose the patient to the reactivation of latent infections such as tuberculosis (TB). Therefore, it is necessary to establish treatment regimens to prevent this. We retrospectively analyzed all consecutive patients undergoing liver transplantation (LT) at our center between January 1, 2000 and December 31, 2010. Latent tuberculosis infections (LTBIs) were diagnosed with positive tuberculin skin test results. After LT, infected patients were treated with isoniazid for 6 months; the treatment began soon after transplantation, and the patients were followed until the end of the study. During this period, 53 patients had LTBI data. All these patients were treated with isoniazid after LT. The median observation period after LT was 52 months (range = 12-129 months). No cases of TB reactivation were reported during follow-up. Only 4 patients presented alterations in liver enzymes related to this treatment, and they showed clear improvement after the treatment was stopped. None of these patients showed severe graft dysfunction. In conclusion, preventive isoniazid appears to be a safe drug for use in LTBI patients after LT. The treatment may be established just after LT without important graft dysfunction or severe consequences for the patient. Liver Transpl, 2012. \u00a9 2012 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.23480","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T21:14:08Z","timestamp":1338326048000},"page":"1110-1117","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Chemoprophylaxis with isoniazid in liver transplant recipients"],"prefix":"10.1097","volume":"18","author":[{"given":"Emilio","family":"F\u00e1brega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Casafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mieses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Moraleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Pons-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20250124","doi-asserted-by":"crossref","first-page":"12661277","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solidorgan transplant recipients: impact and implications for management.","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R2-15-20250124","first-page":"205208","article-title":"Casos de tuberculosis declarados a la Red Nacional de Vigilancia Epidemiologica. Centro Nacional de Epidemiologia.","volume":"18","author":"Rodriguez","year":"2007","journal-title":"Bol Epidemiol Semanal"},{"key":"R3-15-20250124","first-page":"16571665","article-title":"; for Spanish Network for Research in Infectious Diseases. Tuberculosis after solidorgan transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.","volume":"48","author":"TorreCisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R4-15-20250124","doi-asserted-by":"crossref","first-page":"894906","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and metaanalysis of individual patient data.","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"issue":"suppl 4","key":"R5-15-20250124","first-page":"S57S62","article-title":"; for AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients.","volume":"9","author":"Subramanian","year":"2009","journal-title":"Am J Transplant"},{"key":"R6-15-20250124","doi-asserted-by":"crossref","first-page":"633639","DOI":"10.1086\/314007","article-title":"Ridzon R; for Infectious Diseases Society of America. Practice guidelines for the treatment of tuberculosis.","volume":"31","author":"Horsburgh","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R7-15-20250124","first-page":"151","article-title":"American Thoracic Society.","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"R8-15-20250124","first-page":"603662","article-title":"; for American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society. American Thoracic SocietyCenters for Disease Control and PreventionInfectious Diseases Society of America: treatment of tuberculosis.","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-15-20250124","doi-asserted-by":"crossref","first-page":"11291135","DOI":"10.1002\/lt.22133","article-title":"Mycobacterium tuberculosis infection after liver transplantation.","volume":"16","author":"Yehia","year":"2010","journal-title":"Liver Transpl"},{"key":"R10-15-20250124","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1111\/j.1399-0012.1992.tb00596.x","article-title":"Mycobacterium tuberculosis after liver transplantation: management and guidelines for prevention.","volume":"6","author":"Higgins","year":"1992","journal-title":"Clin Transplant"},{"key":"R11-15-20250124","first-page":"10541055","article-title":"Importance of surveillance mycobacterial cultures after liver transplantation.","volume":"60","author":"TorreCisneros","year":"1995","journal-title":"Transplantation"},{"key":"R12-15-20250124","first-page":"555564","article-title":"International Union Against Tuberculosis Committee on Prophylaxis.","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"R13-15-20250124","doi-asserted-by":"crossref","first-page":"13811386","DOI":"10.1097\/00007890-200211270-00006","article-title":"Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area.","volume":"74","author":"Benito","year":"2002","journal-title":"Transplantation"},{"key":"R14-15-20250124","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1097\/00007890-200001150-00013","article-title":"Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.","volume":"69","author":"Meyers","year":"2000","journal-title":"Transplantation"},{"key":"R15-15-20250124","first-page":"364369","article-title":"Isoniazid hepatotoxicity after orthotopic liver transplantation.","volume":"63","author":"Schluger","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"R16-15-20250124","doi-asserted-by":"crossref","first-page":"12781286","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"R17-15-20250124","doi-asserted-by":"crossref","first-page":"10141018","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7year survey from a public health tuberculosis clinic.","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"R18-15-20250124","first-page":"685690","article-title":"Liver transplantation and tuberculosis in Japanese.","volume":"75","author":"Kiuchi","year":"2000","journal-title":"Kekkaku"},{"key":"R19-15-20250124","doi-asserted-by":"crossref","first-page":"11031110","DOI":"10.2169\/internalmedicine.41.1103","article-title":"Clinical analysis of pulmonary tuberculosis in association with corticosteroid therapy.","volume":"41","author":"Kobashi","year":"2002","journal-title":"Intern Med"},{"key":"R20-15-20250124","first-page":"1926","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis.","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R21-15-20250124","doi-asserted-by":"crossref","first-page":"301306","DOI":"10.1097\/00007890-199408000-00008","article-title":"Tuberculosis in liver transplant patients.","volume":"58","author":"Meyers","year":"1994","journal-title":"Transplantation"},{"key":"R22-15-20250124","doi-asserted-by":"crossref","first-page":"207208","DOI":"10.1086\/520159","article-title":"Risk of tuberculosis in tuberculin skin testpositive liver transplant patients.","volume":"29","author":"Chaparro","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R23-15-20250124","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1111\/j.1399-0012.1992.tb00590.x","article-title":"Mycobacterial infection after liver transplantation: a report of three cases and review of the literature.","volume":"6","author":"Sterneck","year":"1992","journal-title":"Clin Transplant"},{"key":"R24-15-20250124","doi-asserted-by":"crossref","first-page":"589592","DOI":"10.1111\/j.1432-2277.1996.tb00919.x","article-title":"Tuberculosis following liver transplantation: report of a case and review of the literature.","volume":"9","author":"Nishizaki","year":"1996","journal-title":"Transpl Int"},{"key":"R25-15-20250124","doi-asserted-by":"crossref","first-page":"229234","DOI":"10.1111\/j.1399-0012.2006.00630.x","article-title":"Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.","volume":"21","author":"Nagai","year":"2007","journal-title":"Clin Transplant"},{"key":"R26-15-20250124","doi-asserted-by":"crossref","first-page":"12761284","DOI":"10.1086\/597590","article-title":"Tuberculosis in solidorgan transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R27-15-20250124","doi-asserted-by":"crossref","first-page":"581587","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants.","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R28-15-20250124","doi-asserted-by":"crossref","first-page":"578590","DOI":"10.1016\/S1473-3099(03)00741-2","article-title":"Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection.","volume":"3","author":"Tufariello","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R29-15-20250124","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target.","volume":"185","author":"Lin","year":"2010","journal-title":"J Immunol"},{"key":"R30-15-20250124","doi-asserted-by":"crossref","first-page":"956973","DOI":"10.1183\/09031936.00120908","article-title":"; for TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"R31-15-20250124","doi-asserted-by":"crossref","first-page":"126156","DOI":"10.1128\/MMBR.00028-07","article-title":"Bacterial growth and cell division: a mycobacterial perspective.","volume":"72","author":"Hett","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"R32-15-20250124","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.jtbi.2011.09.025","article-title":"A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages.","volume":"292","author":"Magombedze","year":"2012","journal-title":"J Theor Biol"},{"key":"R33-15-20250124","doi-asserted-by":"crossref","first-page":"27152729","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation.","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"R34-15-20250124","doi-asserted-by":"crossref","first-page":"603622","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: an update.","volume":"15","author":"Lobue","year":"2010","journal-title":"Respirology"},{"key":"R35-15-20250124","doi-asserted-by":"crossref","first-page":"306314","DOI":"10.1002\/lt.22203","article-title":"Detection and management of latent tuberculosis in liver transplant patients.","volume":"17","author":"Jafri","year":"2011","journal-title":"Liver Transpl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.23480","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201209000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:20:20Z","timestamp":1737739220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201209000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.23480","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}